Middle East Respiratory Syndrome Coronavirus in Bats, Saudi Arabia - Vol. 19 No. 11 - November 2013 - Emerging Infectious Disease journal - CDC
domingo, 10 de noviembre de 2013
Middle East Respiratory Syndrome Coronavirus in Bats, Saudi Arabia - Vol. 19 No. 11 - November 2013 - Emerging Infectious Disease journal - CDC
full-text ►
Middle East Respiratory Syndrome Coronavirus in Bats, Saudi Arabia - Vol. 19 No. 11 - November 2013 - Emerging Infectious Disease journal - CDC

Suggested citation for this article
Middle East Respiratory Syndrome Coronavirus in Bats, Saudi Arabia - Vol. 19 No. 11 - November 2013 - Emerging Infectious Disease journal - CDC
Since Middle East respiratory syndrome (MERS) was described in September 2012, over 90 cases have been reported worldwide, 70 from Saudi Arabia. The incidence of infection with the causative agent, a betacoronavirus (MERS CoV) (1), has not been determined; however, the mortality rate among those who received clinical care is ≈65% (2). Although instances of human-to-human transmission have been documented between case-patients and others in close contact (including hospital patients sharing rooms, family members, and medical personnel), the sources of infection for most patients remain unknown. Because of sequence similarities between β-CoVs identified in bats and those of MERS CoV isolated from humans, a bat reservoir has been posited (3–5). Although neither detection of MERS CoV in bats nor contact of human MERS patients with bats have been reported, a role for bats in human infection cannot be excluded because contact can be indirect (mediated through another animal vector or fomites).
In October 2012 and April 2013, three agencies collected samples from bats in regions where MERS cases had been identified (Figure 1). The agencies are the Ministry of Health of Saudi Arabia, the Center for Infection and Immunity of Columbia University, and EcoHealth Alliance.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario